What are the risk factors for Diabetes?

Ngutiphi tintfo letingabangela kutsi ube nesifo sashukela?

Kunetintfo letinyenti letingenta umuntfu abe nesifo sashukela, letifaka ekhatsi:

1. Umlandvo wemndeni: Kuba nemtali nobe umnakabo lonesifo sashukela kungakhulisa ematfuba ekutsi ube naso.

2. Budzala: Ingoti yekutsi ube nesifo sashukela i-Type 2 iyakhula njengobe uchubeka ukhula, ikakhulukati ngemuva kweminyaka lengu-45 budzala.

3. Sisindvo semtimba: Kuba nesisindvo lesengetiwe nobe kukhuluphala kakhulu kungakhulisa ingoti yekungenwa ngulesifo.

4. Kungenami umtimba: Kungenami umtimba kungakhulisa ingoti yekungenwa ngulesifo.

5. Buve: Bantfu labatsite labavela e-Afrika, eMelika, eMelika lese-Asia, kanye nebantfu labachamuka emaveni lahlukahlukene, basengotini lenkhulu yekungenwa sifo sashukela.

6. Sifo sashukela sekukhulelwa: Besifazane labanaso ngesikhatsi bakhulelwe basengotini lenkhulu yekungenwa sifo sashukela sesibili.

7. Sifo sekuba nema-polycystic ovary syndrome: Besifazane labanaso basengotini lenkhulu yekungenwa sifo sashukela.

8. Sifo sekushintja kwekudla lokudla (metabolic syndrome): Lesifo lesihlanganisa umfutfo wengati lophakeme, i-cholesterol lenyenti kanye nekukhuluphala, sandzisa ematfuba ekutsi ube nesifo sashukela.

9. Kubhema: Kubhema kungenta umuntfu angakhoni kusebentisa i-insulin, lokungabangela kutsi abe nesifo sashukela.

10. Sifo sashukela: Kuba nesifo sashukela nobe kuba nemashukela lamanyenti engatini kungakhulisa ematfuba ekutsi ube nesifo sashukela sesibili.

11. Kutalwa anesisindvo lesincane: Bantfwana labatalwa banesisindvo lesincane basengotini lenkhulu yekungenwa sifo sashukela.

12. Umfutfo wengati lophakeme: Kuba nemfutfo wengati lophakeme kungakhulisa ematfuba ekutsi ube nesifo sashukela.

13. Emazinga langakavami e-cholesterol kanye ne-triglyceride: Emazinga lasetulu e-triglyceride kanye nemazinga laphansi e-HDL (cholesterol lenhle) akhulisa ingoti yekutsi ube nesifo sashukela se-type 2.

14. Kuphefumula kabi nawulala: Bantfu labanenkinga yekuphefumula kabi nabalele basengotini lenkhulu yekungenwa sifo sashukela.

15. Kucindzeteleka: Kucindzeteleka lokungapheli kungakhulisa ematfuba ekutsi ube nesifo sashukela.

16. Imitsi letsite: Leminye imitsi lefaka ekhatsi i-steroid kanye ne-antipsychotic, ingenta umuntfu abe sengotini yekungenwa sifo sashukela.

17. Kuvuvuka: Kuvuvuka lokungapheli kungakhulisa ematfuba ekutsi ube nesifo sashukela.

18. Kuphila ngendlela yekungaphumuli: Kuphila ngendlela yekungaphumuli kungakhulisa ematfuba ekutsi ube nesifo sashukela.

19. Kudla lokunemafutsa lamanyenti kanye nemandla: Kudla lokunemafutsa lamanyenti kanye nemandla kungakhulisa ematfuba ekutsi ube nesifo sashukela.

20. Kunatsa tjwala: Kunatsa kakhulu tjwala kungakhulisa ematfuba ekutsi ube nesifo sashukela.

21. Kulala sikhatsi lesincane: Kulala sikhatsi lesincane kungakhulisa ematfuba ekutsi ube nesifo sashukela.

22. Kungcola kwemoya: Kungcola kwemoya kungakhulisa ematfuba ekutsi ube nesifo sashukela.

23. Tifo letitsite: Tifo letitsite, njengesifo sekusha kwesibindi (hepatitis C), tingenta kutsi ube sengotini yekungenwa sifo sashukela.

24. Umtimba unemafutsa lamanyenti labulala luhlobo lunye lwetifo: Emafutsa lamanyenti labulala luhlobo lolunye lwetifo, kungenta umuntfu abe sengotini yekungenwa sifo sashukela.

25. Kuba ne-uric acid lenyenti: Kuba ne-uric acid lenyenti kungenta umuntfu abe nesifo sashukela.

26. Umsoco lomnyenti we-C-reactive protein: Umsoco lomnyenti we-C-reactive protein, longumkhombandlela wekusha, ungakhulisa ingoti yekutsi ube nesifo sashukela sesibili.

27. Umsoco lomnyenti: Umsoco lomnyenti, longenta ingati ingasheshi ishaye, ungakhulisa ematfuba ekutsi ube nesifo sashukela.

28. I-PAI-1 lenyenti: I-PAI-1 lenyenti, lokuyiprotheni leyenta ingati ingasheshi inyakate, ingenta umuntfu abe sengotini yekungenwa sifo sashukela.

29. Umtimba unemafutsa lamanyenti: Emafutsa lamanyenti, lokuyintfo lelawula sifiso sekudla, angenta umuntfu abe sengotini yekungenwa sifo sashukela.

30. Emazinga lasetulu e-resistin: Emazinga lasetulu e-resistin, lokungumtimba lokhutsata kutsi umuntfu angakhoni kusebentisa i-insulin, angenta umuntfu abe sengotini yekungenwa sifo sekungafuni kusebentisa i-insulin

['Tintfo letibhalwe phansi']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

King WM, Saseen JJ, Anderson SL: Characterization of diabetes risk factors in patients prescribed chronic statin therapy. Ther Adv Chronic Dis. 2014, 5 (5): 206-11.

Bielinski SJ, Pankow JS, Rasmussen-Torvik LJ, Bailey K, Li M, Selvin E, Couper D, Vazquez G, Brancati F: Strength of association for incident diabetes risk factors according to diabetes case definitions: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2012, 175 (5): 466-72.

Gangwisch JE, Gross R, Malaspina D: Differential Associations Between Depression, Risk Factors for Insulin Resistance and Diabetes Incidence in a Large U.S. Sample. Isr J Psychiatry Relat Sci. 2015, 52 (2): 85-90.

Leiva AM, Martínez MA, Petermann F, Garrido-Méndez A, Poblete-Valderrama F, Díaz-Martínez X, Celis-Morales C: [Risk factors associated with type 2 diabetes in Chile]. Nutr Hosp. 2018, 35 (2): 400-407.

Chatterjee R, Maruthur NM, Edelman D: Novel Risk Factors for Type 2 Diabetes in African-Americans. Curr Diab Rep. 2015, 15 (12): 103.

Higa S, Maesato A, Ishigaki S, Suenari K, Chen YJ, Chen SA: Diabetes and Endocrine Disorders (Hyperthyroidism/Hypothyroidism) as Risk Factors for Atrial Fibrillation. Card Electrophysiol Clin. 2021, 13 (1): 63-75.

Brodalko B: [Diabetes risk factors in the Regional Railway Hospital in Lublin, described on the basis of medical documentation]. Wiad Lek. 2000, 53 (5-6): 255-61.

['Sitatimende: setekwelapha']

['Lelikhasi langcondvomshini liniketelwe kufundzisa nekwatisa kuphela futsi alitsatsi seluleko setekwelapha nobe umsebenti wetingcweti.']

['Lemininingwane leniketwako akukafaneli isetjentiselwe kutfola nobe kwelapha tinkinga temphilo nobe tifo, futsi labo labafuna lusito lwetekwelapha kufanele batsintse dokotela lonemvume yekwenta njalo.']

['Uyacelwa kutsi ucaphele kutsi luhlelo lwekuchumana lolwakha timphendvulo temibuto, alukabi kahle kakhulu uma kukhulunywa ngetinombolo. Sibonelo, sibalo sebantfu labanesifo lesitsite.']

['Ngaso sonkhe sikhatsi cela seluleko kudokotela wakho nobe lomunye loniketa lusito lwetemphilo mayelana nesimo sakho sekugula. Ungalokotsi unganaki seluleko sebucwepheshe nobe wephute kusitfola ngenca yalokutsite lokufundze kulewebhusayithi. Uma ucabanga kutsi kungenteka unekugula, shayela 911 nobe uye egunjini lelisedvute lekuphutfuma ngekushesha. Kute budlelwane emkhatsini wetekwelapha nesigulane lobentiwa ngulewebhusayithi nobe kusetjentiswa kwayo. I-BioMedLib nobe basebenti bayo, nobe ngumuphi umuntfu lofaka sandla kulewebhusayithi, akenti nobe nguyiphi imiculu, lechazako nobe lechazako, mayelana nemniningwane loniketwe lapha nobe kusetjentiswa kwayo.']

['Liciniso: copyright']

['Umtsetfo we-Digital Millennium Copyright Act wanga-1998, 17 U.S.C. § 512 (i-DMCA) uniketa indlela yekusitwa kubanikati bemalungelo ekushicilela labakholelwa kutsi tintfo letivela ku-Internet tiphula emalungelo abo ngaphansi kwemtsetfo we-U.S. wekushicilela. ']

['Nangabe ukholelwa kutsi nobe nguyiphi intfo nobe intfo lekhona kulewebhusayithi nobe etinhlelweni tetfu yephula emalungelo akho, wena (nobe ummeli wakho) ungasitfumelela satiso ucele kutsi leyo nto nobe intfo isuswe nobe ivinjelwe.']

['Tatiso kumele titfunyelwe nge-email (buka likheli le-email kusigaba "Sekuchumana").']

['I-DMCA idzinga kutsi satiso sakho sekuhlukumeta emalungelo eluntfu sicukatse lemininingwane lelandzelako: (1) inchazelo yemsebenti logunyatwe emalungelo eluntfu lokutsiwa uphasiwe; (2) inchazelo yalokucuketfwe lokutsiwa kuphasiwe kanye nemininingwane leyenele kutsi sikhone kutfola lokucuketfwe; (3) imininingwane yekutsintsana nawe, kufaka ekhatsi likheli lakho, inombolo yelucingo nelikheli le-email; (4) sitatimende sakho sekutsi unenkolelo lenhle yekutsi lokucuketfwe ngendlela lokhonjiwe akukavumeleki kumnikati wemalungelo eluntfu, nobe kummeli wakhe, nobe ngekusebenta kwanoma ngumuphi umtsetfo; ']

['(5) sitatimende sakho, lesisayinwe ngaphasi kwesijeziso sekufunga emanga, sekutsi umniningwane lokuso satiso ucinisile nekutsi uneligunya lekuvikela emalungelo e-copyright lasolwa kutsi ephuliwe;']

['kanye (6) nekusayina ngekwemtimba nobe nge-elekthroniki kwemnikati we-copyright nobe umuntfu logunyatiwe kutsi ente umsebenti egameni lemnikati we-copyright. ']

['Kwehluleka kufaka yonkhe lemininingwane lengenhla kungaholela ekubambelekeni kwekusetjentwa kwesikhalo sakho.']

['Kuchumana']

['Sicela usitfumelele i-email nganobe nguwuphi umbuto / umbono.']

What are the risk factors for diabetes?

There are several risk factors for diabetes, including:

1. Family history: Having a parent or sibling with diabetes increases your risk.

2. Age: The risk of type 2 diabetes increases as you get older, especially after age 45.

3. Weight: Being overweight or obese increases your risk.

4. Physical inactivity: Lack of exercise can increase your risk.

5. Race or ethnicity: Certain ethnic groups, such as African Americans, Hispanic Americans, Native Americans, and Asian Americans, have a higher risk of developing type 2 diabetes.

6. Gestational diabetes: Women who have had gestational diabetes during pregnancy are at higher risk of developing type 2 diabetes later in life.

7. Polycystic ovary syndrome: Women with this condition have a higher risk of developing type 2 diabetes.

8. Metabolic syndrome: This cluster of conditions, including high blood pressure, high cholesterol, and large waist circumference, increases the risk of type 2 diabetes.

9. Smoking: Smoking can increase insulin resistance, which can lead to type 2 diabetes.

10. Prediabetes: Having prediabetes, or higher than normal blood sugar levels, increases the risk of developing type 2 diabetes.

11. Low birth weight: Babies with low birth weight have a higher risk of developing type 2 diabetes later in life.

12. High blood pressure: Having high blood pressure increases the risk of developing type 2 diabetes.

13. Abnormal cholesterol and triglyceride levels: High levels of triglycerides and low levels of HDL (good) cholesterol increase the risk of type 2 diabetes.

14. Sleep apnea: People with sleep apnea have an increased risk of developing type 2 diabetes.

15. Stress: Chronic stress can increase the risk of developing type 2 diabetes.

16. Certain medications: Some medications, such as steroids and antipsychotics, can increase the risk of developing type 2 diabetes.

17. Inflammation: Chronic inflammation can increase the risk of developing type 2 diabetes.

18. Sedentary lifestyle: A sedentary lifestyle can increase the risk of developing type 2 diabetes.

19. High-fat, high-calorie diet: Consuming a diet high in unhealthy fats and calories can increase the risk of developing type 2 diabetes.

20. Alcohol consumption: Excessive alcohol consumption can increase the risk of developing type 2 diabetes.

21. Sleep deprivation: Inadequate sleep can increase the risk of developing type 2 diabetes.

22. Air pollution: Exposure to air pollution can increase the risk of developing type 2 diabetes.

23. Certain infections: Certain infections, such as hepatitis C, can increase the risk of developing type 2 diabetes.

24. High levels of homocysteine: High levels of homocysteine, an amino acid, can increase the risk of developing type 2 diabetes.

25. High levels of uric acid: High levels of uric acid, a waste product, can increase the risk of developing type 2 diabetes.

26. High levels of C-reactive protein: High levels of C-reactive protein, a marker of inflammation, can increase the risk of developing type 2 diabetes.

27. High levels of fibrinogen: High levels of fibrinogen, a protein involved in blood clotting, can increase the risk of developing type 2 diabetes.

28. High levels of PAI-1: High levels of PAI-1, a protein involved in blood clotting, can increase the risk of developing type 2 diabetes.

29. High levels of leptin: High levels of leptin, a hormone involved in appetite regulation, can increase the risk of developing type 2 diabetes.

30. High levels of resistin: High levels of resistin, a hormone involved in insulin resistance, can increase the risk of developing

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.